English
chinese 
English
Innovation & Investment
BioLife drives innovation across healthcare, digital security, artificial intelligence, supply chain technology, and clean energy. Our investment strategy focuses on accelerating technologies that strengthen long-term societal and industrial value.
Investment Focus
BioLife invests in transformative technologies aligned with our core business ecosystem. Key areas include:
Our goal is to seamlessly integrate advanced technologies with the Group’s global operations.
Private Equity Funds（Fund Portfolio）
BioLife participates in and manages private equity funds dedicated to digital security and artificial intelligence.
These funds serve as strategic engines for technology incubation and industrial upgrading.
Qingdao Liyucheng Equity Investment Fund
Focused on:
Xiamen Chengmei Digital Intelligence Empowerment Equity Investment Fund
Focused on:
Through these funds, BioLife supports early-stage innovation, commercialization pathways, and cross-border industry collaboration.
Incubation Platform
BioLife supports early-stage technologies through a structured incubation platform offering:
1
technical validation
2
regulatory guidance
3
commercialization support
4
access to U.S./Europe/Asia markets
5
strategic investment follow-up
Strategic Portfolio
BioLife’s strategic investments cover multiple sectors including:
Medical device OEM partners
some words
Nutritional science platforms
some words
Global supply chain infrastructure
some words
Toptolife Diagnostics™ (clinic-level diagnostics & compliance systems)
some words
Hydrogen storage & energy technologies
some words
Digital intelligence & AI partners
some words
Our portfolio is built for synergy and long-term value creation.
A global platform integrating healthcare, supply chain, and sustainable energy — headquartered in Hong Kong with operations across the U.S., Italy, and China.
Our Business Divisions
© 2025-2026 BIOLIFE HOLDINGS All rights reserved.